Stylianos Mastronikolis

Dr. Stylianos Mastronikolis

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2022 in Gene
Verified
Journal Article
Closed access
VPVasileios Papanikolaou
Vasileios Papanikolaou
ACAris Chrysovergis
Aris Chrysovergis
VRVasileios Ragos
Vasileios Ragos
ETEVANGELOS TSIAMBAS
EVANGELOS TSIAMBAS
SKSpyros Katsinis
Spyros Katsinis
NMNicholas Mastronikolis
Nicholas Mastronikolis

28 July 2022 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
SMStylianos Mastronikolis
Stylianos Mastronikolis
MPMarina Pagkalou
Marina Pagkalou
PPPanagiotis Plotas
Panagiotis Plotas
KKKonstantinos Kagkelaris
Konstantinos Kagkelaris
CGConstantinos D. Georgakopoulos
Constantinos D. Georgakopoulos
Pseudoexfoliation syndrome (PEXS) is a systemic disease caused by defects in the extracellular matrix (ECM) remodelling process leading to the chronic deposition of extracellular, fibrillary, white flaky pseudoexfoliation material (PEXM) throughout the body. Specifically, PEXM deposits on the lens capsule cause open‑angle glaucoma, cataracts and blindness in patients with PEXS. Several gene single nucleotide polymorphisms are linked to the development of PEXS in humans, including lysyl oxidase‑like 1 gene, clusterin and fibulin‑5. The exact reason for the PEXM generation and its resulting pathogenesis is not well understood. However, defective ECM remodelling and oxidative stress (OS) have been hypothesized as significant events leading to the PEXM. Specifically, the link between OS and PEXS has been well studied, although the investigation is still ongoing. The present review explored recent advances in various aspects of PEXS and the involvement of OS in the eye for PEXS development.

24 February 2022 in IUBMB Life
Verified
Journal Article
Closed access
SMStylianos Mastronikolis
Stylianos Mastronikolis
MPMarina Pagkalou
Marina Pagkalou
GBGiorgos Baroutas
Giorgos Baroutas
KKKONSTANTINA KYRIAKOPOULOU
KONSTANTINA KYRIAKOPOULOU
ΟMΟlga E. Makri
Οlga E. Makri
CGConstantine D Georgakopoulos
Constantine D Georgakopoulos

19 July 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
PSPinelopi Samara
Pinelopi Samara
MAMichail Athanasopoulos
Michail Athanasopoulos
SMStylianos Mastronikolis
Stylianos Mastronikolis
EKEfthymios Kyrodimos
Efthymios Kyrodimos
IAIoannis Athanasopoulos
Ioannis Athanasopoulos
NMNicholas S. Mastronikolis
Nicholas S. Mastronikolis
Head and neck cancers (HNCs) constitute a wide range of malignancies originating from the epithelial lining of the upper aerodigestive tract, including the oral cavity, pharynx, larynx, nasal cavity, paranasal sinuses, and salivary glands. Although lymphomas affecting this region are not conventionally classified as HNCs, they may occur in lymph nodes or mucosa-associated lymphoid tissues within the head and neck. Oncogenic viruses play a crucial role in HNC onset. Human papillomavirus (HPV) is extensively studied for its association with oropharyngeal cancers; nevertheless, other oncogenic viruses also contribute to HNC development. This review provides an overview of the epidemiology, pathogenesis, and advancements in detection methods of oncogenic viruses associated with HNCs, recognizing HPV’s well-established role while exploring additional viral connections. Notably, Epstein–Barr virus is linked to nasopharyngeal carcinoma and lymphomas. Human herpesvirus 8 is implicated in Kaposi’s sarcoma, and Merkel cell polyomavirus is associated with subsets of HNCs. Additionally, hepatitis viruses are examined for their potential association with HNCs. Understanding the viral contributions in the head and neck area is critical for refining therapeutic approaches. This review underlines the interaction between viruses and malignancies in this region, highlighting the necessity for ongoing research to elucidate additional mechanisms and enhance clinical outcomes.

24 June 2021 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
CTChristos Tsilivigkos
Christos Tsilivigkos
SMStylianos Mastronikolis
Stylianos Mastronikolis
SLSPYRIDON LYGEROS
SPYRIDON LYGEROS
DTDimitra Tsilimpoti
Dimitra Tsilimpoti
TPTheodoros Papadas
Theodoros Papadas
Madelung's disease generally refers to a benign symmetrical lipomatosis of the neck, but its presentation can vary. It is treated surgically and different approaches can be implemented. In cases of a threatened airway, a tracheostomy can be performed.

14 December 2022 in Medical Sciences
Verified
Journal Article
Open access
PDF file
SMStylianos Mastronikolis
Stylianos Mastronikolis
Konstantinos KagkelarisKonstantinos Kagkelaris
Konstantinos Kagkelaris
MPMARINA PAGKALOU
MARINA PAGKALOU
ETEVANGELOS TSIAMBAS
EVANGELOS TSIAMBAS
PPPanagiotis Plotas
Panagiotis Plotas
CGConstantine D Georgakopoulos
Constantine D Georgakopoulos
Oxidative stress (OS) affects the anterior ocular tissues, rendering them susceptible to several eye diseases. On the other hand, protection of the eye from harmful factors is achieved by unique defense mechanisms, including enzymatic and non-enzymatic antioxidants. The imbalance between oxidants and antioxidants could be the cause of pseudoexfoliation syndrome (PEXS), a condition of defective extracellular matrix (ECM) remodeling. A systematic English-language literature review was conducted from May 2022 to June 2022. The main antioxidant enzymes protecting the eye from reactive oxygen species (ROS) are superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx), which catalyze the reduction of specific types of ROS. Similarly, non-enzymatic antioxidants such as vitamins A, E and C, carotenoids and glutathione (GSH) are involved in removing ROS from the cells. PEXS is a genetic disease, however, environmental and dietary factors also influence its development. Additionally, many OS products disrupting the ECM remodeling process and modifying the antioxidative defense status could lead to PEXS. This review discusses the antioxidative defense of the eye in association with PEXS, and the intricate link between OS and PEXS. Understanding the pathways of PEXS evolution, and developing new methods to reduce OS, are crucial to control and treat this disease. However, further studies are required to elucidate the molecular pathogenesis of PEXS.